Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Aclaris Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 148
- +13 vs. Q1 2026
- Shares held
- 119.1M
- +9.93M (+9.1%) vs. Q1 2026
- Total value
- $630.0M
- +$220.6M (+53.9%) vs. Q1 2026
- New holders
- 27
- 65 more added
- Sold out
- 14
- 32 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 267,498 | $1.42M | 0.00% | +10,342+4.0% | Added |
| Raymond James Financial Inc | 275,611 | $1.46M | 0.00% | +9,163+3.4% | Added |
| Nuveen, LLC | 278,404 | $1.47M | 0.00% | +160,384+135.9% | Added |
| Bank of New York Mellon Corp | 282,599 | $1.49M | 0.00% | +75,575+36.5% | Added |
| FMR LLC | 313,850 | $1.66M | 0.00% | +137,497+78.0% | Added |
| Charles Schwab Investment Management Inc | 346,058 | $1.83M | 0.00% | +85,068+32.6% | Added |
| Russell Investments Group, Ltd. | 365,055 | $1.93M | 0.00% | +56,890+18.5% | Added |
| Polygon Management Ltd. | 400,000 | $2.12M | 0.34% | +400,000 | New |
| Susquehanna International Group, LLP | 412,549 | $2.18M | 0.00% | +32,619+8.6% | Added |
| D. E. Shaw & Co., Inc. | 414,499 | $2.19M | 0.00% | −486,305−54.0% | Reduced |
| OrbiMed Advisors LLC | 421,500 | $2.23M | 0.04% | +421,500 | New |
| Bollard Group LLC | 431,631 | $2.28M | 0.07% | 00.0% | Unchanged |
| Aisling Capital Management LP | 434,455 | $2.30M | 0.49% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 468,964 | $2.35M | 0.00% | −17,669−3.6% | Reduced |
| Dimensional Fund Advisors LP | 513,840 | $2.71M | 0.00% | +2,379+0.5% | Added |
| Millennium Management LLC | 523,895 | $2.77M | 0.00% | −232,232−30.7% | Reduced |
| Goldman Sachs Group Inc | 609,158 | $3.22M | 0.00% | +20,467+3.5% | Added |
| Three Bridge Wealth Advisors, LLC | 714,823 | $3.78M | 0.95% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 817,531 | $4.32M | 0.01% | +314,900+62.7% | Added |
| Vanguard Fiduciary Trust Co | 907,173 | $4.80M | 0.00% | +278,314+44.3% | Added |
| Aldebaran Capital, LLC | 936,731 | $4.96M | 3.72% | −10,431−1.1% | Reduced |
| Northern Trust Corp | 998,763 | $5.28M | 0.00% | +270,538+37.2% | Added |
| Deutsche Bank AG | 1,040,955 | $5.51M | 0.00% | +43,105+4.3% | Added |
| MPM Oncology Impact Management LP | 1,042,467 | $5.51M | 0.34% | +650,549+166.0% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 1,209,886 | $6.40M | 0.01% | −208,474−14.7% | Reduced |
| Panagora Asset Management Inc | 1,356,152 | $7.17M | 0.02% | +853,862+170.0% | Added |
| Vanguard Portfolio Management LLC | 1,465,735 | $7.75M | 0.00% | −190,331−11.5% | Reduced |
| Woodline Partners LP | 1,611,054 | $8.52M | 0.03% | +125,431+8.4% | Added |
| Palo Alto Investors LP | 1,613,430 | $8.54M | 1.18% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,641,472 | $8.68M | 0.01% | +101,681+6.6% | Added |
| Jones Hill Capital LP | 1,759,492 | $9.31M | 1.98% | +1,759,492 | New |
| Citadel Advisors LLC | 1,762,081 | $9.32M | 0.01% | −487,238−21.7% | Reduced |
| Kalehua Capital Management LLC | 1,832,365 | $9.69M | 5.57% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 1,946,482 | $10.3M | 1.15% | +1,946,482 | New |
| Balyasny Asset Management LLC | 2,023,470 | $10.7M | 0.02% | −1,337,858−39.8% | Reduced |
| Braidwell LP | 2,142,348 | $11.3M | 0.42% | +443,232+26.1% | Added |
| Geode Capital Management, LLC | 3,190,058 | $16.9M | 0.00% | +766,367+31.6% | Added |
| State Street Corp | 3,255,340 | $17.2M | 0.00% | +1,246,594+62.1% | Added |
| Decheng Capital LLC | 4,041,736 | $21.4M | 2.92% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 4,071,000 | $21.5M | 0.03% | +200,000+5.2% | Added |
| Rock Springs Capital Management LP | 4,330,532 | $22.9M | 1.12% | −142,118−3.2% | Reduced |
| Frazier Life Sciences Management, L.P. | 4,925,374 | $26.1M | 0.57% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 5,817,866 | $30.8M | 0.00% | +650,397+12.6% | Added |
| Vivo Capital, LLC | 6,694,637 | $35.4M | 3.23% | +27,971+0.4% | Added |
| Deep Track Capital, LP | 9,345,000 | $49.4M | 0.73% | 00.0% | Unchanged |
| BlackRock, Inc. | 10,037,008 | $53.1M | 0.00% | +2,629,943+35.5% | Added |
| BML Capital Management, LLC | 11,975,000 | $63.3M | 36.18% | −2,275,000−16.0% | Reduced |
| Ra Capital Management, L.P. | 12,723,026 | $67.3M | 0.58% | +5,918,954+87.0% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −712,984−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −213,405−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −194,510−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −132,426−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −118,702−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −97,774−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −33,007−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,294−100.0% | Sold out |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −17,428−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −16,895−100.0% | Sold out |
| MBM Wealth Consultants, LLC | 0 | $0 | 0.00% | −3,198−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |